|
1
|
Yang M, Yuan Y, Zhang H, Yan M, Wang S,
Feng F, Ji P, Li Y, Li B, Gao G, et al: Prognostic significance of
CD147 in patients with glioblastoma. J Neurooncol. 115:19–26. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang KH, Yan MD, Yao CJ, Lin PC and Lai
GM: Honokiol-induced apoptosis and autophagy in glioblastoma
multiforme cells. Oncol Lett. 6:1435–1438. 2013.PubMed/NCBI
|
|
3
|
Williams M, Tietzel I and Quick QA:
1′-Acetoxychavicol acetate promotes caspase 3-activated
glioblastoma cell death by overcoming enhanced cytokine expression.
Oncol Lett. 5:1968–1972. 2013.PubMed/NCBI
|
|
4
|
Wu W, Tian Y, Wan H, Song Y, Li J and
Zhang L: The expressions of Wnt/β-catenin pathway-related
components in brainstem gliomas. Can J Neurol Sci. 40:355–360.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huo HN, Xie KP, Wang LM, Jiang Y, Zou W
and Xie MJ: Relationship between the inhibitory effect of fraxetin
on breast cancer and estrogen signaling pathway. Sheng Li Xue Bao.
65:323–328. 2013.(In Chinese). PubMed/NCBI
|
|
6
|
Kang P, Wan M, Huang P, Li C, Wang Z,
Zhong X, Hu Z, Tai S and Cui Y: The Wnt antagonist SFRP1 as a
favorable prognosticator in human biliary tract carcinoma. PLoS
One. 9:e903082014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crooks V, Waller S, Smith T and Hahn TJ:
The use of the Karnofsky Performance Scale in determining outcomes
and risk in geriatric outpatients. J Gerontol. 46:M139–M144. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lyros O, Rafiee P, Nie L, Medda R,
Jovanovic N, Schmidt J, Mackinnon A, Venu N and Shaker R:
Dickkopf-1, the Wnt antagonist, is induced by acidic pH and
mediates epithelial cellular senescence in human reflux
esophagitis. Am J Physiol Gastrointest Liver Physiol.
306:G557–G574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stoehr R, Wissmann C, Suzuki H, Knuechel
R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, et
al: Deletions of chromosome 8p and loss of SFRP1 expression are
progression markers of papillary bladder cancer. Lab Invest.
84:465–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kocemba KA, Groen RW, van Andel H, Kersten
MJ, Mahtouk K, Spaargaren M and Pals ST: Transcriptional silencing
of the Wnt-antagonist DKK1 by promoter methylation is associated
with enhanced Wnt signaling in advanced multiple myeloma. PLoS One.
7:e303592012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takada T, Yagi Y, Maekita T, Imura M,
Nakagawa S, Tsao SW, Miyamoto K, Yoshino O, Yasugi T, Taketani Y
and Ushijima T: Methylation-associated silencing of the Wnt
antagonist SFRP1 gene in human ovarian cancers. Cancer Sci.
95:741–744. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong CM, Fan ST and Ng IO: beta-Catenin
mutation and overexpression in hepatocellular carcinoma:
Clinicopathologic and prognostic significance. Cancer. 92:136–145.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oikonomou E, Barreto DC, Soares B, De
Marco L, Buchfelder M and Adams EF: Beta-catenin mutations in
craniopharyngiomas and pituitary adenomas. J Neurooncol.
73:205–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salaroli R, Di Tomaso T, Ronchi A,
Ceccarelli C, Cammelli S, Cappellini A, Martinelli GN, Barbieri E,
Giangaspero F and Cenacchi G: Radiobiologic response of
medulloblastoma cell lines: involvement of beta-catenin. J
Neurooncol. 90:243–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji H, Wang J, Fang B, Fang X and Lu Z:
α-Catenin inhibits glioma cell migration, invasion and
proliferation by suppression of β-catenin transactivation. J
Neurooncol. 103:445–451. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Wang H, Makki MS, Wen J, Dai Y,
Shi Q, Liu Q, Zhou X and Wang J: Overexpression of β-catenin and
cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.
Int J Clin Exp Pathol. 7:264–271. 2013.PubMed/NCBI
|
|
17
|
Ji L, Cao XF, Wang HM, Li YS, Zhu B, Xiao
J and Wang D: Expression level of beta-catenin is associated with
prognosis of esophageal carcinoma. World J Gastroenterol.
13:2622–2625. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delic S, Lottmann N, Stelzl A, Liesenberg
F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, et
al: MiR-328 promotes glioma cell invasion via SFRP1-dependent
Wnt-signaling activation. Neuro Oncol. 16:179–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meng Y, Wang QG, Wang JX, Zhu ST, Jiao Y,
Li P and Zhang ST: Epigenetic inactivation of the SFRP1 gene in
esophageal squamous cell carcinoma. Dig Dis Sci. 56:3195–3203.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki H, Gabrielson E, Chen W, Anbazhagan
R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB: A
genomic screen for genes upregulated by demethylation and histone
deacetylase inhibition in human colorectal cancer. Nat Genet.
31:141–149. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caldwell GM, Jones C, Gensberg K, Jan S,
Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM and Morton DG:
The Wnt antagonist SFRP1 in colorectal tumorigenesis. Cancer Res.
64:883–888. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suzuki M, Shigematsu H, Nakajima T, Kubo
R, Motohashi S, Sekine Y, Shibuya K, Iizasa T, Hiroshima K and
Nakatani Y: Synchronous alterations of Wnt and epidermal growth
factor receptor signaling pathways through aberrant methylation and
mutation in non small cell lung cancer. Clin Cancer Res.
13:6087–6092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sogabe Y, Suzuki H, Toyota M, Ogi K, Imai
T, Nojima M, Sasaki Y, Hiratsuka H and Tokino T: Epigenetic
inactivation of SFRP genes in oral squamous cell carcinoma. Int J
Oncol. 32:1253–1261. 2008.PubMed/NCBI
|
